QTRX logo

Quanterix (QTRX) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

07 December 2017

Indexes:

Not included

Description:

Quanterix Corporation develops an ultra-sensitive platform for digital immunoassay and tools for medical-biological research and diagnostics. The company offers a single molecule platform (Simoa) that uses single molecule measurements to detect protein biomarkers. The company also focuses on implementing and developing new treatment and diagnostic methods, making medical services easier for early detection, monitoring, prognosis, and ultimately disease prevention. Simoa specializes in research and clinical trials and significantly advances the enzyme-linked immunosorbent assay (ELISA) technology, providing unprecedented sensitivity in protein detection. Quanterix Corporation was founded in 2007, with its headquarters located in Billerica, Massachusetts.

Key Details

Price

$12.95

Annual Revenue

$121.14 M(+15.42% YoY)

Annual EPS

-$0.86(+67.05% YoY)

Beta

1.81

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

13 Nov '24 TD Cowen
Hold
12 Aug '24 Scotiabank
Sector Outperform
09 Aug '24 TD Cowen
Hold
09 July '24 Goldman Sachs
Buy
29 Apr '24 Canaccord Genuity
Buy
04 Mar '24 Scotiabank
Sector Outperform
28 Sept '23 Goldman Sachs
Buy
27 Sept '23 Goldman Sachs
Buy
25 Sept '23 Canaccord Genuity
Buy
09 Aug '23 Goldman Sachs
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
QTRX
globenewswire.com28 November 2024

NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ: QTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Quanterix Corporation (QTRX) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Quanterix Corporation (QTRX) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Quanterix Corporation (QTRX) And Encourages Stockholders to Reach Out
QTRX
accesswire.com27 November 2024

NEW YORK CITY, NY / ACCESSWIRE / November 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX). Investors who purchased Quanterix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/QTRX.

Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
QTRX
prnewswire.com27 November 2024

NEW YORK , Nov. 27, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ: QTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public. So What: If you purchased Quanterix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Quanterix Corporation Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm
Quanterix Corporation Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm
Quanterix Corporation Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm
QTRX
accesswire.com26 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Quanterix Corporation For Fraud
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Quanterix Corporation For Fraud
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Quanterix Corporation For Fraud
QTRX
accesswire.com25 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
QTRX
globenewswire.com24 November 2024

NEW YORK, Nov. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ: QTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public.

Quanterix Corporation Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
Quanterix Corporation Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
Quanterix Corporation Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
QTRX
accesswire.com24 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Quanterix Corporation (QTRX) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Quanterix Corporation (QTRX) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Quanterix Corporation (QTRX) and Encourages Stockholders to Learn More About the Investigation
QTRX
accesswire.com24 November 2024

NEW YORK CITY, NY / ACCESSWIRE / November 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX). Investors who purchased Quanterix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/QTRX.

The Schall Law Firm Wants Shareholders To Join An Inquiry Into Quanterix Corporation For Defrauding The Public
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Quanterix Corporation For Defrauding The Public
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Quanterix Corporation For Defrauding The Public
QTRX
accesswire.com23 November 2024

LOS ANGELES, CA / ACCESSWIRE / November 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
QTRX
prnewswire.com22 November 2024

NEW YORK , Nov. 22, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ: QTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public. So What: If you purchased Quanterix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

FAQ

  • What is the primary business of Quanterix?
  • What is the ticker symbol for Quanterix?
  • Does Quanterix pay dividends?
  • What sector is Quanterix in?
  • What industry is Quanterix in?
  • What country is Quanterix based in?
  • When did Quanterix go public?
  • Is Quanterix in the S&P 500?
  • Is Quanterix in the NASDAQ 100?
  • Is Quanterix in the Dow Jones?
  • When was Quanterix's last earnings report?
  • When does Quanterix report earnings?
  • Should I buy Quanterix stock now?

What is the primary business of Quanterix?

Quanterix Corporation develops an ultra-sensitive platform for digital immunoassay and tools for medical-biological research and diagnostics. The company offers a single molecule platform (Simoa) that uses single molecule measurements to detect protein biomarkers. The company also focuses on implementing and developing new treatment and diagnostic methods, making medical services easier for early detection, monitoring, prognosis, and ultimately disease prevention. Simoa specializes in research and clinical trials and significantly advances the enzyme-linked immunosorbent assay (ELISA) technology, providing unprecedented sensitivity in protein detection. Quanterix Corporation was founded in 2007, with its headquarters located in Billerica, Massachusetts.

What is the ticker symbol for Quanterix?

The ticker symbol for Quanterix is NASDAQ:QTRX

Does Quanterix pay dividends?

No, Quanterix does not pay dividends

What sector is Quanterix in?

Quanterix is in the Healthcare sector

What industry is Quanterix in?

Quanterix is in the Medical Devices industry

What country is Quanterix based in?

Quanterix is headquartered in United States

When did Quanterix go public?

Quanterix's initial public offering (IPO) was on 07 December 2017

Is Quanterix in the S&P 500?

No, Quanterix is not included in the S&P 500 index

Is Quanterix in the NASDAQ 100?

No, Quanterix is not included in the NASDAQ 100 index

Is Quanterix in the Dow Jones?

No, Quanterix is not included in the Dow Jones index

When was Quanterix's last earnings report?

Quanterix's most recent earnings report was on 12 November 2024

When does Quanterix report earnings?

The next expected earnings date for Quanterix is 27 February 2025

Should I buy Quanterix stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions